Lexicon Pharmaceuticals surges as Cantor Fitzgerald sees unencumbered path in HCM
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 1.55 -0.01 (0.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.56 | 52 Week High | $19.62 | |||
| Open | $1.56 | 52 Week Low | $7.65 | |||
| Day High | $1.59 | P/E | N/A | |||
| Day Low | $1.54 | EPS | $-0.22 | |||
| Volume | 376,670 | |||||
